Note: Ingredients listed on restricted chemical lists
EC/CAS
57-55-6
Name of the chemical
1,2-propanediol
Concentration
≥1.0-≤5.0
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
≤1.0
General Information
Version
13
Revision date
2019-11-16
Product name
LN-700 SM PROJCTS 4PK AHE70004TN0
1.2.1 Relevant identified uses
Industrial applications
Manufacturer Name
PPG Industries, Inc
Emergency telephone
52 55 5559 1588, 1-800-441-9695
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H350
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
25% (Oral), 58.6% (Dermal), 29.4% (Inhalation)
Signal word
Danger
Hazard statements
May cause cancer.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves. Wear eye or face protection. Wear protective clothing.
Response
IF exposed or concerned: Get medical attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Sanding and grinding dusts may be harmful if inhaled. This product contains crystalline silica which can cause lung cancer or silicosis. The risk of cancer depends on the duration and level of exposure to dust from sanding surfaces or mist from spray applications. This product either contains formaldehyde or is capable of releasing formaldehyde above 0.5 ppm under certain conditions. Formaldehyde is a known cancer hazard, a skin sensitizer and a respiratory sensitizer. Emits toxic fumes when heated.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 25% (Oral), 58.6% (Dermal), 29.4% (Inhalation)